Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria (LAB), is a gram positive, spore-forming bacterium utilized as a probiotic. Bacillus coagulans is non-pathogenic, beneficial and safe for human
Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria (LAB), is a gram positive, spore-forming bacterium utilized as a probiotic. Bacillus coagulans is non-pathogenic, beneficial and safe for human consumption. It is used in various therapeutic treatments such as digestive problems, diarrhea, constipation, lactose intolerance, bacterial vaginosis, cholesterol reduction and immunity enhancement. Bacillus coagulans is compatible with vitamins, enzymes, electrolytes, proteins and carbohydrates, which makes it a cost-effective probiotic that can be incorporated into a wide range of foods. Bacillus coagulans is GRAS affirmed and being a tough and stable probiotic that can withstand a harsh acidic environment, it is a popular probiotic choice in food and pharmaceutical industries.
Request a Sample of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-8434
Bacillus Coagulans – A Safe, Natural and Effective Way to Balance Intestinal System and Maintain Strong Immune and Digestive System
The bacillus coagulans market is driven by applications in functional foods and beverages such as breakfast cereals, sports beverages, protein bars and shakes and bakery products. Bacillus coagulans is a suitable choice for bakery products as it can withstand high temperatures required during baking. Besides usage in the food and beverages industry, bacillus coagulans also finds application in the supplements sector as a probiotic. With rising health concerns among the global population, probiotics have been witnessing high demand, which in turn has been driving the demand for bacillus coagulans. The use of probiotics containing bacillus coagulans is a safe, natural and effective way to balance the intestinal system and maintain a strong immune and digestive system.
The lack of awareness among consumers regarding the effectiveness of bacillus coagulans restricts the growth of the market to an extent. The increasing demand for bacillus coagulans products in emerging economies is expected to provide growth opportunities for market participants.
Global Bacillus Coagulans Market: Market Participants
Sabinsa Corp., Mitsubishi, Syngen Biotech Co., Unique Biotech, Aumgene Bioscience, Microbax, JBH Biotech, sanzyme are some of the key players identified in the global Bacillus coagulans market.
Global Bacillus Coagulans Market: Key Developments
Increasing investments on R&D activities to launch innovative products in functional foods are propelling the bacillus coagulans market growth. Across the globe, strains expressing unique and particular characteristics are of great interest. Although a reasonable number of commercial probiotic strains are available, novel strains with better potency are being continuously searched, which may enable health benefits with the specific targeted functional properties. Manufacturers are focusing on developing innovative and effective solutions through fermentation technology to improve the overall yield and quality of the product.
On 14th September, 2017, Sabinsa Corp. was successfully granted a U.S. patent for its shelf stable probiotic LactoSpore® Bacillus coagulans product combined with cranberry seed fibers. With the aid of natural fiber from cranberry, the viable colony count of the bacillus coagulans was found to increase. Studies have shown that lactospore® is found to reverse depression symptoms in patients suffering from IBS as well as improve cholesterol levels.
Global Bacillus Coagulans Market: Opportunities for Market Participants
Asia Pacific holds a substantial revenue share in the global bacillus coagulans market with ASEAN, India, and China pegged to be prominent markets for bacillus coagulans. North America is pegged to be next in line after Asia Pacific. Asia Pacific is also projected to be a fast growing market, owing to the rising healthcare spending in the region.
Japan is pegged to be a significant market for bacillus coagulans in the probiotics sector, owing to its widespread awareness about herbal medicine in the region. Also, Southeast Asian countries such as India are expected to bolster the bacillus coagulans market growth with the increased adoption of healthcare products.
Ask An Analyst @
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8434
The report covers exhaust analysis on:
Regional analysis includes:
Bacillus Coagulans Market: Segmentation
Segmentation of the bacillus coagulans market on the basis of the type:
Segmentation of the bacillus coagulans market on the basis of the end use:
Segmentation of the bacillus coagulans market on the basis of the distribution channel:
Buy Complete Report @
https://www.futuremarketinsights.com/checkout/8434
Download complimentary copy of Future Market Insights White Paper in collaboration with PBFIA, on the Plant Based Market that throws light on potential opportunities and investments made in the Global plant based market
About FMI Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Bacillus Coagulans Market size , Bacillus Coagulans Market outlook , Bacillus Coagulans Market keytrends , Bacillus Coagulans Market review , Bacillus Coagulans Market Forecast
Jul 25, 2022
Copyright © 2006 - 2023 PRnob Media, UBIC Solutions, LLC. All Rights Reserved.
